Ali Catherine Devine, PA-C

Ali Devine practices at Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health.

Ali Devine's NPI, 1730833492, was assigned on February 10, 2022. Ali Devine holds Florida license 9115484.

Ali Devine's primary practice is Baptist Medical Center Jacksonville, at 800 Prudential Dr, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-2000.

Ali Devine's primary practice is Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health. Ali Devine is also affiliated with Ascension St. Vincent's Riverside. The medical group on file is Northeast Florida Endocrine and Diabetes Associates. Dmand AI also links Ali Devine to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ali Devine practices, 7 sites in all. Vendor and product names are available with a free account.

Physician assistant is Ali Devine's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Ali Devine is licensed in Florida.

Dmand AI lists diabetic emergency among the conditions Ali Devine treats.

CMS data shows 1,482 Medicare services from Ali Devine across 4 procedure codes in 2024, for 771 Medicare patients. Medicare paid $80,814 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 771 Medicare patients who saw Ali Devine in 2026. The largest group is 75 to 84, with 333 patients. 75% of them have diabetes, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ali Devine's median patient age at 65, with 48% women.

In 2026, Ali Devine wrote 187 Medicare Part D claims for 83 patients. 17% of them were for generic drugs. CMS names the drug for 101 of them, across 6 drugs with 11 or more claims each, at $23,068 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Ali Devine for performance year 2026, reported through an alternative payment model (APM). Ali Devine accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 20 general payments to Ali Devine from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $335.